Liu Dian-Gang, Zhang Yu-Xian, Li Fei
Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, P.R. China.
Oncol Lett. 2012 Feb;3(2):391-394. doi: 10.3892/ol.2011.462. Epub 2011 Oct 26.
Langerhans cell histiocytosis (LCH) is a rare disease of unknown etiology characterized by oligoclonal proliferation of Langerhans cells. The diagnosis of LCH is complicated by the fact that it may involve multiple organ systems and its clinical presentation and course varies, ranging from an isolated to a multisystem disease. We report a 35-year-old male with LCH involving multiple systems, including the bones, lungs, spleen, liver and bile ducts, whose first clinical presentation was liver dysfunction. The patient was diagnosed following a skull biopsy that revealed infiltration of Langerhans cells. However, a liver biopsy revealed sclerosing cholangitis (SC) with no signs of Langerhans cell infiltration, and the clinical manifestations of the involved organs were atypical, leading to a delayed diagnosis. The patient was in partial remission following chemotherapy. In conclusion, findings of this case may aid our understanding of the pathophysiology of LCH and in improving its diagnosis and treatment.
朗格汉斯细胞组织细胞增多症(LCH)是一种病因不明的罕见疾病,其特征为朗格汉斯细胞的寡克隆增殖。LCH的诊断较为复杂,因为它可能累及多个器官系统,其临床表现和病程各不相同,从孤立性疾病到多系统疾病不等。我们报告一例35岁男性LCH患者,累及多个系统,包括骨骼、肺、脾脏、肝脏和胆管,其首发临床表现为肝功能障碍。患者经颅骨活检显示朗格汉斯细胞浸润后确诊。然而,肝脏活检显示硬化性胆管炎(SC),无朗格汉斯细胞浸润迹象,且受累器官的临床表现不典型,导致诊断延迟。患者化疗后部分缓解。总之,该病例的发现可能有助于我们理解LCH的病理生理学,并改善其诊断和治疗。